Bellus Health Company

BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys.

Last Funding Type: Post-IPO Equity
Total Funding: $44.6M
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Technology: Cancer
Founded Date: 2010
Headquarters: Canada
Industry: PharmTech
Acquisitions Number: 2